Valuation: IRIDEX Corporation

Market Cap 20.37M 17.82M 16.37M 15.26M 28.88M 1.94B 29.43M 197M 76.36M 952M 76.46M 74.79M 3.28B P/E 2026 *
-22.8x
P/E 2027 * 57x
Enterprise Value 20.37M 17.82M 16.37M 15.26M 28.88M 1.94B 29.43M 197M 76.36M 952M 76.46M 74.79M 3.28B EV / Sales 2026 *
0.38x
EV / Sales 2027 * 0.36x
Free-Float
68.77%
Yield 2026 *
-
Yield 2027 * -
1 day-3.42%
1 week-5.04%
Current month-1.31%
1 month+1.80%
3 months+19.00%
6 months-0.88%
Current year-0.88%
1 week 1.12
Extreme 1.12
1.2
1 month 1.09
Extreme 1.09
1.2
Current year 0.95
Extreme 0.9496
1.65
1 year 0.87
Extreme 0.8688
1.65
3 years 0.78
Extreme 0.782
3.65
5 years 0.78
Extreme 0.782
9.46
10 years 0.78
Extreme 0.782
16.64
Manager TitleAgeSince
Chief Executive Officer 54 30/09/2024
Director of Finance/CFO 68 17/12/2018
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 23/06/2020
Director/Board Member 54 31/08/2018
Director/Board Member 66 16/03/2022
Date Insider Type Main position Quantity % Market Cap.
06-12Tax

Chief Financial Officer

-2,691 0.0155%
06-12Tax

Chief Executive Officer

-3,990 0.0229%
06-11Buy

Chief Financial Officer

975 0.0056%
Change 5-day change 1-year change 3-year change Capi.($)
-3.42%-5.04%+26.95%-47.93% 20.37M
+1.97%+6.35%+24.19%+0.32% 191B
+5.87%+6.02%-20.81%+24.59% 143B
+2.17%+4.80%-1.58%-17.53% 137B
+4.83%+1.53%-56.92%-16.55% 64B
+2.59%+5.25%+22.27%+0.04% 52.97B
+1.39%+2.13%-25.49%-32.59% 43.82B
-2.02%-0.71%+8.50%+8.68% 37.67B
+0.31%+2.74%+6.23%+42.30% 37.13B
+1.09%+1.06%-13.67%-19.29% 29.5B
Average +0.46%+1.96%-3.03%-5.79% 73.55B
Weighted average by Cap. +1.17%+3.37%-2.72%+0.01%

Financials

2026 *2027 *
Net sales 53M 46.37M 42.6M 39.71M 75.15M 5.06B 76.6M 513M 199M 2.48B 199M 195M 8.55B 56.77M 49.66M 45.63M 42.53M 80.49M 5.41B 82.04M 549M 213M 2.65B 213M 208M 9.15B
Net income -795K -696K -639K -596K -1.13M -75.83M -1.15M -7.69M -2.98M -37.15M -2.98M -2.92M -128M 361K 316K 290K 270K 512K 34.43M 522K 3.49M 1.35M 16.87M 1.36M 1.33M 58.21M
Net Debt - -
Logo IRIDEX Corporation
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Employees
93
Date Price Change Volume
02/07/26 US$1.140 -2.56% 27,466
01/07/26 US$1.170 +2.18% 9,856
30/06/26 US$1.145 +0.88% 23,577
29/06/26 US$1.135 +0.44% 57,032
26/06/26 US$1.130 -4.24% 29,320
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.140USD
Average target price
2.750USD
Spread / Average Target
+141.23%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRIX Stock